Overview
GRGDS, amide is a bioactive peptide that plays a crucial role in cell adhesion studies, particularly in cancer research. This peptide is specifically known for inhibiting the adhesion of human ovarian carcinoma OVCAR-3 cells to fibronectin without affecting their adhesion to laminin. When you’re exploring options for studying cell interactions, GRGDS, amide is a valuable addition to your laboratory toolkit, making it easier to investigate ovarian cancer cell behavior and the mechanisms behind tumor progression.
Key Features
- Inhibits OVCAR-3 cell adhesion to fibronectin
- Identifies cell adhesion mechanisms in cancer research
- High purity and quality for reliable results
- Ideal for experimental applications in oncology
- Part of our extensive peptides collection
Specifications
| Product Name | GRGDS, amide |
| Weight | 5 mg |
| Category | Peptides |
FAQ
What is the primary use of GRGDS, amide?
GRGDS, amide is primarily used in cancer research to study the adhesion properties of ovarian carcinoma cells, helping to understand their interactions with the extracellular matrix.
How is GRGDS, amide delivered?
This peptide is typically delivered in a lyophilized form, ensuring stability and ease of use in various experimental setups.
Can GRGDS, amide be used in combination with other substrates?
Yes, GRGDS, amide can be effectively used with other substrates for enhanced studies. For instance, you might consider pairing it with PKG Substrate for comprehensive adhesion analysis.




Reviews
There are no reviews yet.